Cutaneous nerve endings

Cutaneous nerve endings are the peripheral terminations of primary afferent sensory neurons located within the epidermis and dermis of the skin (StatPearls, 2023). They function as the body's primary interface with the environment, containing specialized receptors for mechanoreception, thermoreception, and nociception (NIH, 2024). These endings include encapsulated structures like Meissner's corpuscles and free nerve endings that express various ion channels such as TRPV1 and voltage-gated sodium channels (Nav1.7, Nav1.8) (Nature Reviews Disease Primers, 2016). In clinical practice, these endings are the site of action for topical analgesics like lidocaine, which blocks sodium channels to prevent action potential propagation, and capsaicin, which desensitizes TRPV1-expressing nociceptors (British Journal of Anaesthesia, 2008). Pathological conditions such as small fiber neuropathy are characterized by the degeneration of these endings, often measured by intraepidermal nerve fiber density (IENFD) via skin biopsy (Journal of Investigative Dermatology, 2010). Chronic inflammation or nerve injury can lead to the sensitization of these terminals, resulting in allodynia or hyperalgesia. Therapeutic strategies often focus on stabilizing these membranes or reducing the density of overactive fibers to manage chronic pain and itch.

Other names

Sensory nerve endingsPeripheral nerve terminalsCutaneous receptorsIntraepidermal nerve fibers (IENF)

Modulation of sensory transduction and action potential propagation via inhibition of voltage-gated sodium channels or desensitization of transient receptor potential (TRP) channels.